Manuscripts and Letters

2020 -Ming G. Chai, Menino O. Cotta, Mohd H. Abdul-Aziz, Jason A. Roberts, What Are the Current Approaches to Optimising Antimicrobial Dosing in the Intensive Care Unit? Pharmaceutics 2020, 12(7), 638

2020 -Wannee Kantasiripitak, Ruth Van Daele, Matthias Gijsen, Marc Ferrante, Isabel Spriet,Erwin Dreesen, Software Tools for Model-Informed Precision Dosing: How Well Do They Satisfy the Needs? Front. Pharmacol., 07 May 2020

2020 – Silva SD, Alves GCS, Chequer FMD, Farkas A, Daróczi G, Roberts JA, Sanches C. Linguistic and cultural adaptation to the Portuguese language of antimicrobial dose adjustment software. einstein (São Paulo). 2020;18:eAO5023.

2019 – Minyon L Avent, B. A. Rogers. Optimising antimicrobial therapy through the use of Bayesian dosing programs. International Journal of Clinical Pharmacy, August 2019, 41(6).

2018 – Dhaese SA, Farkas A, Colin P, Lipman J, Stove V, Verstraete AG, Roberts JA, De Waele JJ. Population pharmacokinetics and evaluation of the predictive performance of pharmacokinetic models in critically ill patients receiving continuous infusion meropenem: a comparison of eight pharmacokinetic models. J Antimicrob Chemother. 2018 Oct 30.

2018 – Drennan, Philip; Doogue, Matthew; van Hal, Sebastiaan J; Chin, Paul, Bayesian therapeutic drug monitoring software: past, present and future. International Journal of Pharmacokinetics; 2018, Vol. 3, (4).

2018 – Emily L. Heil, David P. Nicolau, Andras Farkas, Jason A. Roberts, Kerri A. Thom; Pharmacodynamic target attainment for cefepime, meropenem and piperacillin/tazobactam using a pharmacokinetic/pharmacodynamic-based dosing calculator in critically ill patients. Antimicrobial Agents and Chemotherapy, published online ahead of print on June 6, 2018

2018 – Aminoglycoside Dosing in Adults, Published by the State of Queensland (Queensland Health), April 2018

2016 – Andras Farkas, Gergely Daroczi, Philip Villasurda, Michael Dolton, Midori Nakagaki, Jason A Roberts; Comparative evaluation of the predictive performance of three different structural population pharmacokinetic models to predict future voriconazole concentrations. Antimicrobial Agents and Chemotherapy, published online ahead of print on September 6, 2016

2016 – Delgado-Valverde M, Torres E, Valiente-Mendez A, Almirante B, Gómez-Zorrilla S, Borrell N, Corzo JE, Gurgui M, Almela M, García-Álvarez L, Fontecoba-Sánchez MC, Martínez-Martínez L, Cantón R, Praena J, Causse M, Gutiérrez-Gutiérrez B, Roberts JA, Farkas A, Pascual Á, Rodríguez-Baño J; REIPI/GEIH-SEIMC BACTERAEMIA-MIC group; Impact of the MIC of piperacillin/tazobactam on the outcome for patients with bacteraemia due to Enterobacteriaceae: the Bacteraemia-MIC project. 2016, Journal of Antimicrobial Chemotherapy, 71(2):521-30

2014 – Gloria Wong, Andras Farkas, Rachel Sussman, Gergely Daroczi, William W Hope, Jeffrey Lipman, Jason A Roberts; Comparison of the accuracy and precision of pharmacokinetic equations to predict free meropenem concentrations in critically ill patients. Antimicrobial Agents and Chemotherapy, published online ahead of print on 15 December 2014

2014 – Jason A Roberts, Mohd H Abdul-Aziz, Jeffrey Lipman, Johan W Mouton, Alexander A Vinks, Timothy W Felton,William W Hope,  Andras Farkas, Michael N Neely, Jerome J Schentag, George Drusano, Otto R Frey, Ursula Theuretzbacher,  Joseph L Kuti, on behalf of The International Society of Anti-Infective Pharmacology and the Pharmacokinetics and Pharmacodynamics Study Group of the European Society of Clinical Microbiology and Infectious Diseases; Individualised antibiotic dosing for patients who are critically ill: challenges and potential solutions. 2014,  The Lancet Infectious Diseases, 14 (6): 441 – 532

2012 – Farkas A, Successful target attainment of telavancin at elevated MICs: fact or fiction?  2012, Antimicrobial Agents and Chemotherapy, 56: 4560